2004 Porsche 911 on 2040-cars
San Diego, California, United States
Transmission:Manual
Fuel Type:Gasoline
For Sale By:Private Seller
Vehicle Title:Finance Owing, Encumbered
Engine:Flat 6 3.6L 315 hp
VIN (Vehicle Identification Number): WP0CA29934S650149
Mileage: 97000
Make: Porsche
Model: 911
Interior Color: Black
Number of Seats: 4
Number of Previous Owners: 2
Number of Cylinders: 6
Drive Type: AWD
Drive Side: Left-Hand Drive
Exterior Color: Silver
Car Type: Performance Vehicle
Number of Doors: 2
Features: Air Conditioning, Alarm, AM/FM Stereo, CD-Changer, CD Player, Climate Control, Cruise Control, Electric Mirrors, Leather Interior, Leather Seats, Power Locks, Power Seats, Power Steering, Power Windows
Porsche 911 for Sale
2022 porsche 911 gt3 coupe(US $249,999.00)
2024 porsche 911 carrera s coupe 2d(US $220,000.00)
1997 porsche 911 cabriolet(US $500.00)
2015 porsche 911 turbo s(US $67,950.00)
2020 porsche 911 carrera(US $109,000.00)
1989 porsche 911 1-owner, g50, top quality, serviced, complete porsche(US $119,000.00)
Auto Services in California
Zoe Design Inc ★★★★★
Zee`s Smog Test Only Station ★★★★★
World Class Collision Ctr ★★★★★
WOOPY`S Auto Parts ★★★★★
William Michael Automotive ★★★★★
Will Tiesiera Ford Inc ★★★★★
Auto blog
Porsche again staring down another $1.8B in hedge fund lawsuits
Wed, 15 May 2013The sequence of events from 2007 that began with Porsche's secret attempt to take over Volkswagen, and instead lead to Porsche being taken over by VW, continues to instigate lawsuits against the Stuttgart sports car manufacturer. A group of hedge funds that suffered over $1 billion in losses sued the car company in New York. Porsche had publicly stated it wasn't trying to buy VW, the hedge funds in question were shorting VW stock, and when Porsche's actual intentions were revealed, the stock shot up and the hedge funds took a beating.
The case was thrown out over the issue of jurisdiction, then appealed, only to see another suit filed on top of that. After that, most of the hedge funds withdrew their claims in New York and Porsche offered a 90-day window to refile in Germany where it is already fighting a number of other suits over the same issue. The hedge funds accepted the offer, refiling in Stuttgart for $1.8 billion in damages. According to Bloomberg, Porsche hasn't commented on the refiling, but as the same plaintiffs are involved, it's safe to assume that the carmaker still feels the case is "unsubstantiated and without merit." It has fared alright so far even in German courts, with two lesser cases against it thrown out last year.
The 2014 Porsche Cayenne Turbo S brings 50 extra ponies to Detroit
Mon, 14 Jan 2013Porsche has announced a new version of its popular SUV today at the Detroit Auto Show: the 550-horsepower 2014 Cayenne Turbo S.
This newly minted "flagship" of the Cayenne lineup is powered by a twin-turbocharged 4.8-liter V8 engine, and offers 50 hp more than the Cayenne Turbo. Performance figures are impressive for the sleek utility vehicle: 0-60 miles per hour can be dashed off in 4.3 seconds, while maximum speed is rated at 175 mph. The Turbo S also gets dynamic chassis control, torque vectoring and Porsche's Sport Chrono package - all standard equipment.
Visually the Cayenne Turbo S differentiates itself from the lesser models in pretty subtle ways. Gloss black trim decorates the gawping front air intakes, as well as rear-view mirror trim panel. The SUV also wears 21-inch Turbo II wheels, a la the 911 Turbo.
Porsche suspends ties with Maria Sharapova after drug test
Tue, Mar 8 2016Porsche has reportedly suspended ties with Maria Sharapova after the Russian tennis star failed a drug test. The German automaker stopped short of terminating its relationship with the athlete altogether as it awaits the results of a deeper investigation. The issue emerged at the Australian Open, where Sharapova reportedly tested positive for use of a drug called meldonium. Manufactured in Latvia and prescribed in many former Soviet Bloc countries, meldonium is used to treat heart conditions and improve cardiac circulation. It is not approved by the FDA for use in the United States, and the World Anti-Doping Agency added it to its list of prohibited substances at the start of this year. Sharapova admitted that she's been taking the medication for ten years now but that she did not keep up to date on the WADA's list. Since it is considered a prohibited substance, she's been excluded from participating in the Australian Open this year, and suspended from competition as of March 12. She was also scheduled to take part in the Porsche Grand Prix, a tennis event sponsored by the carmaker in Stuttgart next month which she will now apparently have to miss. One of the top-rated female tennis players in the world, Sharapova has served as a brand ambassador for Porsche since 2013. Other sponsors including TAG Heuer and Nike have also reportedly suspended their relationships with the athlete pending further investigation by the International Tennis Federation. Related Video:













